• Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts

    Source: Buzz FX / 21 Dec 2024 02:07:12   America/Chicago


    Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Average Rating of "Moderate Buy" by Analysts Written by MarketBeat December 21, 2024 Share Link copied to clipboard. Shares of Amicus Therapeutics, Inc. ( NASDAQ:FOLD - Get Free Report ) have be
    Read more...
Share on,